Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

The impact of cruciate ligament rupture on osteoarthritis of the knee

Study links tears of anterior cruciate ligament to increased risk and severity of disease even among patients with no recall of significant knee injury.

2 Mar 2005

A shallow hip socket predicts osteoarthritis of the hip

Long-term study suggests moderate acetabular dysplasia, a developmental condition of hip instability, as an independent risk factor for the disease.

2 Mar 2005

Liquorice - the black stuff we love to eat, may help prevent cancer

Liquorice - the black stuff we love to eat, contains a compound - glycyrrhizic acid which may stop people with a herpes virus from developing cancer.A research team at New York University found the compound - glycyrrhizic acid - possibly has the ability to stop the virus triggering a form of cancer called Kaposi sarcoma.

2 Mar 2005

FDA wants full authority to control labeling for drugs

Sandra L. Kweder, FDA's deputy director for new drugs, wants Congress to issue the FDA with the authority to control labeling for drugs to stop the prolonged disputes on this matter.

2 Mar 2005

Nature’s most sophisticated biological weapon

Nature’s most sophisticated biological weapon, snake venom, largely evolved from bits of body parts a Melbourne researcher has found.

1 Mar 2005

New research offers natural alternative to arthritis drugs

The research, conducted by The Australian Centre for Complementary Medicine Education and Research (ACCMER), shows that Biolane Green Lipped Mussel Extract has a combination of actions that are not associated with increased risk of blood clotting that has caused recent drug withdrawals and medical warnings. In fact, the product may even help slow the progression of osteoarthritis.

1 Mar 2005

Aggressive industry promotion of prescription drugs may be a danger to patients and doctors

Vioxx, Celebrex and Bextra hit the market in the late 1990s & 2001, as a breakthrough class of drugs for arthritis that would help avoid ulcers and other digestive ailments linked to medicines such as aspirin.

28 Feb 2005

Surgical treatment of hip or knee arthritis does not reduce obesity

A number of arthritis sufferers attribute their weight gain to inactivity due to a painful hip or knee. These patients may be disheartened when their post-operative weight either remains the same or increases.

27 Feb 2005

Cigarette smokers have an increased risk of experiencing rotator cuff tears

Cigarette smokers have an increased risk of experiencing rotator cuff tears in their shoulders than their tobacco-free counterparts, according to study results presented today at the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons.

27 Feb 2005

Ankle sprains may predispose a patient to osteoarthritis

Ankle sprains may predispose a patient to osteoarthritis according to a study presented at the American Orthopaedic Foot and Ankle Society’s Annual Winter Meeting in Washington, DC.

27 Feb 2005

Measuring hyaluronan in joints and fluid that lubricates cartilage might enable doctors to diagnose osteoarthritis more accurately

Measuring a biological chemical called hyaluronan found naturally in joints and the fluid that lubricates cartilage might enable doctors to diagnose osteoarthritis of the knee and hip earlier or more accurately, a new study concludes.

27 Feb 2005

New imaging technology may serve as objective outcome measures for orthopedic conditions

New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."

27 Feb 2005

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Scientists at the University of Maryland School of Medicine in Baltimore have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease.

23 Feb 2005

Feverfew or Bachelor's Button, kills human leukemia stem cells like no other single therapy

A daisy-like plant known as Feverfew or Bachelor's Button, a traditional remedy for reducing fevers and a treatment for nervousness, hysteria and low spirits, is the source of an agent that kills human leukemia stem cells like no other single therapy

23 Feb 2005

People drink less alcohol as they age

A new UCLA study shows that people drink less alcohol as they age--but drinking among those who were born in earlier years showed a faster decline than among people born more recently.

22 Feb 2005

Lack of collagen increases likelihood of osteoarthritis

Duke University Medical Center researchers have found that joints whose cartilage lacks a specific type of collagen will develop osteoarthritis – the so-called "wear-and-tear" form of the disease – at a greatly accelerated rate.

20 Feb 2005

Biologic therapies are changing the way dermatologists treat psoriasis

Recently approved and investigational biologic therapies are changing the way dermatologists treat psoriasis, a chronic disease that physically and emotionally challenges 4.5 million Americans. As more research is conducted into the effectiveness of these biologics, they are showing great promise for improving the health and well-being of patients with psoriasis.

20 Feb 2005

Vioxx doubles risk of heart attacks and strokes

The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.

15 Feb 2005

Renovis announces investigational medicine for multiple sclerosis study

Renovis announced today the initiation of a Phase Ia clinical trial for REN-850, an investigational oral small molecule that is being targeted for the treatment of multiple sclerosis (MS).

14 Feb 2005

Paradox suggests reasons why COX-2 inhibitors hurt and help

Laboratory studies at Johns Hopkins have revealed that certain products of the enzymes COX-1 and COX-2 can both protect and damage the brain. The findings, published in the February 2005 issue of the Journal of Neurochemistry, offer tantalizing clues to why drugs like Vioxx and Celebrex, which block COX-2, can ease arthritis but potentially harm the heart and brain.

14 Feb 2005